AARDVARK THERAPEUTICS, INC. Earnings Per Share (Basic)
AARDVARK THERAPEUTICS, INC. (AARD) reported Earnings Per Share (Basic) of -$0.66 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- AARDVARK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.66.
- AARDVARK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.99.
- AARDVARK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.81.
- AARDVARK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.75.
- AARDVARK THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$2.93.
- AARDVARK THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$5.15.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.66 10-Q · filed 2026-08-11 | -$1.65 10-Q · filed 2026-08-11 | -$2.45 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$3.21 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.99 10-Q · filed 2026-05-07 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$2.55 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$3.21 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$2.22 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$2.93 10-K · filed 2026-03-23 |
| 2025-09-30 | -$0.75 10-Q · filed 2025-11-13 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$2.12 10-Q · filed 2025-11-13 | -$3.22 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.66 10-Q · filed 2026-08-11 | -$1.36 10-Q · filed 2026-08-11 | -$2.50 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$3.41 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.71 10-Q · filed 2026-05-07 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$3.14 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$4.40 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$2.16 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$3.22 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$4.60 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$5.15 10-K · filed 2026-03-23 |
| 2024-09-30 | -$1.05 10-Q · filed 2025-11-13 | -$2.42 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$2.97 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.37 10-Q · filed 2025-08-13 | -$1.92 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$0.55 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |